Astrana Health, Inc. (ASTH) - Form 8-K Summary
Business Context and Reporting Period
Astrana Health, Inc., a Delaware corporation, filed this Current Report on Form 8-K on August 6, 2026. The filing announces the Company's financial results for the three and six months ended June 30, 2026. The Company's common stock trades on The Nasdaq Stock Market LLC under the symbol "ASTH."
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) and supplemental data (Exhibit 99.2) for detailed financial figures. Consequently, this specific text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics for the reported periods.
Material Changes
The filing text does not contain specific data regarding material changes in financial condition or results of operations compared to prior periods. Such details are contained within the referenced press release and supplemental exhibits.
Guidance, Outlook, and Management Commentary
Management has scheduled a conference call and webcast for August 6, 2026, at 2:30 p.m. Pacific Time to discuss the financial results. An earnings presentation is available on the Company's investor relations website. The filing text does not include specific forward-looking guidance, risk factors, or management commentary beyond the announcement of the results.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the three and six months ended June 30, 2026.
- Examine Exhibit 99.2 (Supplemental Data) for non-GAAP financial measures and detailed operational metrics.
- Verify the Company's liquidity position and debt obligations as detailed in the referenced exhibits.
- Listen to the conference call or review the earnings presentation for management's outlook and discussion of material changes.